Elizabeth A Doyle BolandSummaryAffiliation: Yale University Country: USA Publications
| Collaborators
|
Detail Information
Publications
A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargineElizabeth A Doyle
Department of Pediatrics and Children s Clinical Research Center, Yale University School of Medicine, New Haven, Connecticut, USA
Diabetes Care 27:1554-8. 2004..Our principal aim in this short-term study was to compare the efficacy of CSII to MDI with glargine in lowering HbA(1c) levels in children and adolescents with type 1 diabetes...
Case study: contrasting challenges of insulin pump therapy in a toddler and adolescent with type 1 diabetesElizabeth A Doyle Boland
Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA
Diabetes Educ 31:584-90. 2005..To describe the challenges and outcomes of continuous subcutaneous insulin infusion (CSII) pump therapy in a toddler and adolescent with type 1 diabetes. Insight into patient-family aspects motivating pump use is provided...
Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up reportStuart A Weinzimer
Department of Pediatrics, Yale University School of Medicine, PO Box 208064, 333 Cedar St, New Haven, Connecticut 06520, USA
Pediatrics 114:1601-5. 2004..The objective of this study was to analyze the CSII efficacy and safety data in very young children with type 1 diabetes from our Diabetes Clinic database...
Disease management in the young diabetic patient: glucose monitoring, coping skills, and treatment strategiesStuart A Weinzimer
Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA
Clin Pediatr (Phila) 44:393-403. 2005..Overall, careful management, monitoring, and education can improve glycemic control and yield positive treatment outcomes in the child or adolescent with diabetes...
